ArticleIntestinal research2026

Effectiveness, safety, and pharmacokinetics of the infliximab biosimilar CT-P13 after non-medical switch from the infliximab originator in patients with inflammatory bowel disease.

Ryohei Nomaru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.